Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Increase the proportion of women at risk for unintended pregnancy who use effective birth control — FP‑10 Data Methodology and Measurement

On this page:  About this objective  |  Methodology  |  History

About this objective

Data

Data Source:  National Survey of Family Growth (NSFG), CDC/NCHS

National baseline: 58.3 percent of women aged 20 to 49 years at risk of unintended pregnancy used most effective or moderately effective methods of contraception in 2022-23

National target: 63.2 percent

Numerator
Number of women aged 20 to 49 years who are currently using most effective or moderately effective methods of contraception.
Denominator
Number of women aged 20 to 49 years who are at risk of unintended pregnancy.
National target-setting method
Percentage point improvement
National target-setting method details
Percentage point improvement from the baseline using Cohen's h effect size of 0.10.
1
National target-setting method justification
Trend data were not available for this objective. A percentage point improvement was calculated using Cohen's h effect size of 0.1. This method was used because it was a statistically significant improvement from the baseline.
National data collection frequency
Periodic

Methodology

Questions used to obtain the national baseline data

(For additional information, please visit the data source page linked above.)

From the 2022-2023 National Survey of Family Growth:

CONSTAT1-CONSTAT4 recodes are used to measure current contraceptive status.

  1. Female sterilization
  2. Male sterilization
  3. Hormonal implant
  4. Depo-Provera (injectable)
  5. Pill
  6. Contraceptive Patch
  7. Contraceptive Ring
  8. Emergency contraception
  9. IUD
  10. Diaphragm (with or w/out jelly or cream)
  11. Male Condom
  12. Female condom/vaginal pouch
  13. Foam
  14. Cervical cap
  15. Today Sponge
  16. Suppository or insert
  17. Jelly or cream (not with diaphragm)
  18. Periodic abstinence: NFP, cervical mucus test or temperature rhythm
  19. Periodic abstinence: calendar rhythm
  20. Withdrawal
  21. Other method
  22. Pregnant
  23. Seeking Pregnancy
  24. Postpartum
  25. Sterile—nonsurgical—female
  26. Sterile—nonsurgical—male
  27. Sterile—surgical—female (noncontraceptive)
  28. Sterile—surgical—male (noncontraceptive)
  29. Sterile—unknown reasons—male
  30. Other nonuser—never had intercourse
  31. Other nonuser—has had intercourse, but not in the 3 months prior to survey
  32. Other nonuser—had intercourse in the 3 months prior to survey

HADSEX: Whether respondent has ever had sexual intercourse with a male (Recode).

  1. Yes
  2. No

AGER: Respondent age at survey (Recode): 20-49

Methodology notes

The most effective methods of contraception are: male or female sterilization, implants, and intrauterine device. Moderately effective methods of contraception are: injectables, oral pills, contraceptive patch, or contraceptive ring.

At risk of unintended pregnancy is defined as women who have ever had sex (with a man), are not sterile (for surgical noncontraceptive or nonsurgical reasons), or are neither pregnant, seeking pregnancy, nor postpartum.

History

Comparable HP2020 objective
Retained, which includes core objectives that are continuing from Healthy People 2020 with no change in measurement.
Revision History
Revised. 

In 2026, following a redesign of the NSFG survey, the baseline for this objective was revised from 60.3% as reported in 2015-2017 to 58.3% as reported in 2022-2023. Using the original target-setting method, the target was also updated from 65.1% to 63.2%.

1. Effect size h=0.1 was chosen to correspond with 10% improvement from a baseline of 50%.